Special Issue "Oncogenes in Cancer 2.0"
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 3766
This Special Issue is the second edition of a previous one, “Oncogenes in Cancer”.
The first oncogenes were discovered more than three decades ago. Since then, remarkable development has been achieved by the scientific community unraveling the biological impact of these oncogenes in the development and progression of different neoplasms as well as their potential clinical applicability in the design of targeted therapies. All this knowledge has made it possible to conceive of the personalized treatment of cancer.
In this Special Issue entitled “Oncogenes in Cancer”, we approach the role of actionable genomic somatic alterations able to drive different solid tumors, their biological context, and the different therapeutic strategies evaluated.
This Special Issue is conceived as a comprehensive review of the most frequently present oncogenes in major solid malignancies, updating the most relevant advances leading to the development and eventual approval of new targeted therapeutic compounds.
Dr. Ignacio Gil-Bazo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- driver oncogenes
- personalized medicine
- targeted therapies
- somatic mutations